[HTML][HTML] S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular …

F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang… - … and Targeted Therapy, 2021 - nature.com
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis.

F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang… - Signal Transduction …, 2021 - europepmc.org
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis

Y Fei, X Lin, Z Chen, Y Fanli, S Lin… - Signal Transduction …, 2021 - search.proquest.com
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis

F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang… - … and Targeted Therapy, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> SARS-CoV-2 recognizes, via its spike receptor-
binding domain (S-RBD), human angiotensin-converting enzyme 2 (ACE2) to initiate …

[PDF][PDF] S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular …

2021 - scholar.archive.org
In the end of 2019, a novel coronavirus, designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), suddenly emerged and swiftly spread globally. 1-3 Despite of …

[PDF][PDF] S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular …

2021 - scienceopen.com
In the end of 2019, a novel coronavirus, designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), suddenly emerged and swiftly spread globally. 1-3 Despite of …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis

F Ye, X Lin, Z Chen, F Yang, S Lin… - Signal transduction …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis.

F Ye, X Lin, Z Chen, F Yang, S Lin… - … & Targeted Therapy, 2021 - search.ebscohost.com
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis

F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang, H Chen… - 2021 - agris.fao.org
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …

[HTML][HTML] S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular …

F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang… - Signal Transduction …, 2021 - ncbi.nlm.nih.gov
Abstract SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human
angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 …